Form 4: Agilent Technologies CEO Sells Shares Under 10b5-1 Plan

Agilent Technologies' CEO, Padraig McDonnell, sold 1,911 shares of common stock at $150 per share on January 21, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Padraig McDonnell, the President and CEO of Agilent Technologies, sold 1,911 shares of the company's common stock on January 21, 2025.
• The sale was executed at a price of $150 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 8, 2024.
• Following the transaction, Mr. McDonnell directly owns 39,652 shares of Agilent common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, which is neither positive nor negative for the company's outlook.

Industry Context

Executive stock sales are a common occurrence and are often pre-planned under Rule 10b5-1 to avoid accusations of insider trading. This transaction is a routine disclosure and does not necessarily indicate a change in the company's outlook.

Comparison to Industry Standards

• Rule 10b5-1 trading plans are a standard practice among executives at publicly traded companies, including competitors like Thermo Fisher Scientific and Danaher.
• The volume of shares sold is relatively small compared to the total outstanding shares of Agilent, which is typical for these types of transactions.
• The price of $150 per share is within the normal trading range for Agilent stock at the time of the transaction.

Stakeholder Impact

• The stock sale by the CEO may have a minor impact on shareholder sentiment, but it is unlikely to significantly affect the stock price due to the pre-planned nature of the transaction.

Key Dates

Keywords

Agilent Technologies, Padraig McDonnell, stock sale, Rule 10b5-1, insider trading, executive transaction